Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

Skye Bioscience to Present at TD Cowen Health Care Conference
Posted On Thursday, February 20, 2025
Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025
Posted On Thursday, February 20, 2025
Society for Clinical Research Sites (SCRS) and Fortrea Partner to Advance Collaboration in Clinical Research
Posted On Thursday, February 20, 2025
Aquestive Therapeutics to Report Fourth Quarter 2024 Financial Results and Recent Business Highlights on March 5 and Host Conference Call on March 6 at 8:00 a.m. ET
Posted On Thursday, February 20, 2025
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
Posted On Thursday, February 20, 2025
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Business Updates
Posted On Thursday, February 20, 2025
RetinalGenix Technologies Breakthrough in Real-Time 24/7 Remote Ocular Monitoring
Posted On Thursday, February 20, 2025
FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million
Posted On Thursday, February 20, 2025
Apellis and Sobi Announce EMA Validation of Indication Extension Application for Aspaveli® (pegcetacoplan) for C3G and Primary IC-MPGN
Posted On Thursday, February 20, 2025
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
Posted On Wednesday, February 19, 2025
ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March
Posted On Wednesday, February 19, 2025
PacBio to Participate in TD Cowen's 45th Annual Health Care Conference
Posted On Wednesday, February 19, 2025
Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025
Posted On Wednesday, February 19, 2025
GRI Bio Announces Reverse Stock Split
Posted On Wednesday, February 19, 2025
Relay Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights on February 26, 2025
Posted On Wednesday, February 19, 2025
NurExone Biologic Recognized as a 2025 TSX Venture 50™ Top Performing Stock
Posted On Wednesday, February 19, 2025
COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Posted On Wednesday, February 19, 2025
Better Choice Company Adjourns Special Meeting of Stockholders to March 21, 2025
Posted On Wednesday, February 19, 2025
Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate
Posted On Wednesday, February 19, 2025
Intrommune Therapeutics Announces Publication of OMEGA Study in Peanut Allergic Adults in Annals of Allergy, Asthma & Immunology
Posted On Wednesday, February 19, 2025
OrphAI Therapeutics Announces Appointment of Dr. Aaron Waxman to Board of Directors
Posted On Wednesday, February 19, 2025
NAYA Biosciences Announces Nomination of New Board Members
Posted On Wednesday, February 19, 2025
Kaida BioPharma Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Posted On Wednesday, February 19, 2025
GRI Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Posted On Wednesday, February 19, 2025
Palisade Bio, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Posted On Wednesday, February 19, 2025

Print